AN2 Therapeutics, Inc.(ANTX)
盘后1.070.01+1.41%17:55 EDT
1.06+0.01+0.48%
登录后可参与评论
- 08-28Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]超过5%披露Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 08-19Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-15Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 08-15Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 08-14Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]超过5%披露Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 08-13Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]超过5%披露Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 08-13Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 08-13Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-12Form SC 13G - Statement of Beneficial Ownership by Certain Investors超过5%披露Form SC 13G - Statement of Beneficial Ownership by Certain Investors
- 08-08Form 8-K - Current report重要事件披露Form 8-K - Current report
- 07-03Form SC 13G - Statement of Beneficial Ownership by Certain Investors超过5%披露Form SC 13G - Statement of Beneficial Ownership by Certain Investors
- 06-25Form 8-K - Current report重要事件披露Form 8-K - Current report
- 05-14Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 05-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 05-14Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend][修订]年度报告Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
最高
1.07
今开
1.06
量比
0.71
最低
1.04
昨收
1.05
换手率
1.91%
热议股票
关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策
公司名称：北京至简风宜信息技术有限公司
违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）
© 2018-2024 老虎社区 版权所有
营业执照：91110105MA01A4U55R
ICP备：京ICP备18016422号
关注我们